Martine Gouldstone, CEO updates investors on Oncimmune’s new strategy

26 October 2023

On the 26th October 2023, Oncimmune’s CEO Martin Gouldstone presented at the Holdings PLC Investors presentation, to reintroduce the company following the sale of the early lung CDC detection business earlier this year and provide an update of the strategy and focus moving forward. Click the video below to find out more.